About

The King Center for Lynch Syndrome at Penn Medicine's Abramson Cancer Center is dedicated to the clinical care of individuals with Lynch syndrome, as well as to advancing education, outreach, and research related to this hereditary condition.  Affecting approximately 1 in 279 individuals, Lynch syndrome is one of the most common hereditary cancer predisposition syndromes. Learn more here.

The King Center is the first comprehensive Lynch Syndrome Center in the mid-Atlantic and the first named and endowed Lynch Syndrome Center worldwide. A pioneering hub dedicated to advancing the understanding, prevention, and treatment of hereditary cancer, the King Center for Lynch Syndrome fosters interdisciplinary collaboration among scientists, clinicians, and genetic counselors to translate cutting-edge research into life-saving care. The King Center is committed to empowering individuals and families affected by Lynch Syndrome through education, genetic testing, personalized risk management strategies, and state-of-the-art treatments.

From genetic counseling and comprehensive medical management to innovative research and community outreach, the King Center aims to reduce the burden of hereditary cancers and improve outcomes for those with Lynch syndrome.